SHC News & Events

Sotera Health announced the appointment of Alton Shader to the role of CEO of the company, effective May 26, as part of a planned leadership transition. Shader will succeed Michael Petras, chairman and CEO, who will serve as executive chairman. "Alton's strong commercial experience and track-record of driving growth in the healthcare industry makes him a great fit for Sotera Health," said Michael Petras. Shader has served as CEO and director of Viant Medical since 2019 and brings over 20 years of deep medical industry experience. At Viant, he successfully led the company through a period of accelerated growth by expanding the global manufacturing footprint and strengthening its end-to-end capabilities through targeted acquisitions.

Backs FY26 revenue view $1.23B-$1.25B, consensus $1.24B. Backs FY26 adjusted EBITDA view $632M-$641M. The company said, "The outlook provided above contains a number of assumptions, including, among others, the Company's current expectations regarding supply chain continuity, particularly for the supply of ethylene oxide and Cobalt-60, and the impact of inflationary trends including their impact on energy prices and the supply of labor."

Reports Q1 revenue $280.05M, consensus $270.77M. "We delivered a strong start to the year, with solid revenue and Adjusted EBITDA growth while driving margin expansion," said Chairman and Chief Executive Officer, Michael B. Petras, Jr. "Growth was driven by disciplined execution at Sterigenics and Nordion, and Nelson Labs came in as we outlined on our fourth-quarter 2025 earnings call. Based on our first-quarter performance, we are reaffirming our 2026 outlook and remain confident in our trajectory for the remainder of the year."